Canyon Capital Advisors LLC Acorda Therapeutics Inc Transaction History

Canyon Capital Advisors LLC

  • $531 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$0.3 - $1.67 $163,487 - $910,078
544,957 Added 83.96%
1,193,988 $556,000
Q4 2021

Feb 14, 2022
BUY
$2.3 - $4.71 $589,092 - $1.21 Million
256,127 Added 65.19%
649,031 $1.55 Million
Q2 2021

Aug 16, 2021
BUY
$3.61 - $5.23 $709,487 - $1.03 Million
196,534 Added 100.08%
392,904 $1.87 Million
Q1 2021

May 17, 2021
BUY
$3.8 - $8.04 $746,206 - $1.58 Million
196,370 New
196,370 $956,000

Others Institutions Holding ACOR

# of Institutions
1
Shares Held
133K
Call Options Held
0
Put Options Held
0
View Full List

About ACORDA THERAPEUTICS INC

ACOR Quotes by TradingView
  • Ticker ACOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 24,338,400
  • Market Cap $6.33M
  • Description
  • Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also...
More about ACOR
Track This Portfolio

Track Canyon Capital Advisors LLC Portfolio

Follow Canyon Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canyon Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Canyon Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email